skip to main content
US FlagAn official website of the United States government
dot gov icon
Official websites use .gov
A .gov website belongs to an official government organization in the United States.
https lock icon
Secure .gov websites use HTTPS
A lock ( lock ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.


Title: Biopharmaceutical Manufacturing: Historical Perspectives and Future Directions
This review describes key milestones related to the production of biopharmaceuticals—therapies manufactured using recombinant DNA technology. The market for biopharmaceuticals has grown significantly since the first biopharmaceutical approval in 1982, and the scientific maturity of the technologies used in their manufacturing processes has grown concomitantly. Early processes relied on established unit operations, with research focused on process scale-up and improved culture productivity. In the early 2000s, changes in regulatory frameworks and the introduction of Quality by Design emphasized the importance of developing manufacturing processes to deliver a desired product quality profile. As a result, companies adopted platform processes and focused on understanding the dynamic interplay between product quality and processing conditions. The consistent and reproducible manufacturing processes of today's biopharmaceutical industry have set high standards for product efficacy, quality, and safety, and as the industry continues to evolve in the coming decade, intensified processing capabilities for an expanded range of therapeutic modalities will likely become routine.  more » « less
Award ID(s):
2100502
PAR ID:
10424485
Author(s) / Creator(s):
;
Date Published:
Journal Name:
Annual Review of Chemical and Biomolecular Engineering
Volume:
13
Issue:
1
ISSN:
1947-5438
Page Range / eLocation ID:
141 to 165
Format(s):
Medium: X
Sponsoring Org:
National Science Foundation
More Like this
  1. Lee, G.M.; Kildegaard, H. Faustrup; Lee, S.Y. (Ed.)
    Host cell protein (HCP) impurities, endogenous proteins expressed from host cells, can challenge biopharmaceutical manufacturing. Certain HCPs can persist even after downstream purification, leading to adverse impacts on drug stability and potentially, patient safety. Thus, the quantification and control of HCPs is critical. Although many improvements have been made in HCP quantification and control methods, HCP-associated risks cannot be completely eliminated. A better biophysical understanding of Chinese hamster ovary (CHO) HCPs and advancement of monitoring assays will lead to better controlled biopharmaceutical manufacturing. This chapter will discuss (i) current HCP removal processes for various product types, (ii) the impact of residual HCPs on drug efficacy and safety, (iii) HCP quantification and monitoring methods such as proteomics approaches and enzyme-linked immunosorbent assays (ELISA) using anti-HCP antiserum, (iv) HCP control approaches in both upstream and downstream processes, and (v) future directions for effective HCP risk management strategies. 
    more » « less
  2. Industrial biotechnology and biopharmaceutical manufacturing leverage biology to enable cellular systems to serve as factories to produce molecules of value to humankind. These biotechnological processes utilize diverse host organisms and address applications from biofuel, polymer building blocks, antibiotics, and whole cell therapies. Industrial biotechnology can address environmental and sustainability goals in addition to chemical production. In a similar fashion, the field of biopharmaceutical manufacturing has and continues to produce life-saving medicines. Despite these diverse applications, these fields rely on common biological themes and require similar approaches for genetic and metabolic engineering as discussed in this review. Through advances in synthetic biology, targeted genetic engineering, DNA sequencing, adaptation and high-throughput screening, industrial biotechnology and biopharmaceutical manufacturing utilize the same framework for efficient biochemical production which can be leveraged in current and future collaborations to enable rapid innovation. 
    more » « less
  3. Research shows that there is a growing need for skilled workers in the area of advanced manufacturing; this refers to making use of new technologies and advanced processes to produce products that have high value. More importantly, U.S. government employment data reveals that there is lack of supply of skilled workers in the manufacturing sector. Furthermore, it has also been widely cited in industrial literature that there is a concern regarding the job readiness of fresh college graduates and the gaps in skills sets needed to be successful in an industrial setting, especially in the engineering or manufacturing fields. One approach to bridge the skills gap is to provide customized continuing education to current the workforce as per the industry need. This paper presents a case study of such customized continuing education offered by Texas A&M University for oil and gas industry in Houston, Texas. Specifically, as a part of National Science Foundation Advanced Technological Education project, two professional development sessions were organized in the summer of 2018 in Houston targeting the energy industry. Both programs were two-days long and focused on two key aspects of high value manufacturing: manufacturing operations excellence and manufacturing quality excellence. The professional development sessions were focused on materials and inventory planning, production economics, manufacturing quality, non-destructive evaluation, statistical process control, and lean/ sixsigma. The continuing education programs and course materials were developed based on the feedback from the industry advisory board for the Manufacturing Center of Excellence at Houston Community College, which is a collaborating partner on the ATE Grant. As a part of assessment of the programs, industry participants in the both sessions were given comprehensive surveys asking for their feedback on the applicability of the educational sessions. Overall, the participants rated the sessions very highly on the organization and the relevancy of the program topics and learning materials. The participants also felt that they learned new information through these programs. 
    more » « less
  4. Advanced manufacturing techniques such as Additive Manufacturing (AM) have grown rapidly in major industries such as aerospace, automotive, and biomedical device manufacturing. Biomedical industry has benefitted immensely from AM because of its flexibility in design and its rapid production cycle. Powder bed processes are the major production technique for metal-based AM implants. This paper serves as a comprehensive review on the research efforts being made using AM to develop new patient centered medical devices. This review focuses on AM of the most common metals for biomedical applications, Magnesium alloys, Cobalt-Chromium alloys, pure Titanium, Titanium alloys. Several different aspects are discussed including biocompatibility and osseointegration, application of specific metals in different types of implants, their advantages and disadvantages, mechanical properties in comparison to bone, and their production technologies. Regulatory and quality assurance hurdles that are facing new innovations made using AM are discussed. 
    more » « less
  5. Metal additive manufacturing (AM) is gaining increasing attention from academia and industry due to its unique advantages compared to the traditional manufacturing process. Parts quality inspection is playing a crucial role in the AM industry, which can be adopted for product improvement. However, the traditional inspection process has relied on manual recognition, which could suffer from low efficiency and potential bias. This study presented a convolutional neural network (CNN) approach toward robust AM quality inspection, such as good quality, crack, gas porosity, and lack of fusion. To obtain the appropriate model, experiments were performed on a series of architectures. Moreover, data augmentation was adopted to deal with data scarcity. L2 regularization (weight decay) and dropout were applied to avoid overfitting. The impact of each strategy was evaluated. The final CNN model achieved an accuracy of 92.1%, and it took 8.01 milliseconds to recognize one image. The CNN model presented here can help in automatic defect recognition in the AM industry. 
    more » « less